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Silver  nanoparticles  (AgNPs)  induce  the  production  of  reactive  oxygen  species  (ROS) and
apoptosis.  These  effects  are  enhanced  by  smaller  particles.  Using  live-cell  imaging,  we  show
that AgNPs  induced  ROS  production  rapidly  in  a size-dependent  manner  after  exposure  of
cells to  70-nm  and 1-nm  AgNPs  (AgNPs-70,  AgNPs-1),  but not  AgNO3. Exposure  of cells  to
5 g/mL  each  of  AgNPs-70,  AgNPs-1  or AgNO3 for  1 h  decreased  the  cell  viability  by approx-
imately  40%,  100%  and  20%,  respectively.  ROS  were  rapidly  induced  after  5 and  60 min  by
AgNPs-1  and  AgNPs-70,  respectively,  whereas  AgNO3 had no  detectable  effect.  ROS  produc-Nanomaterial
Oxidative stress
Nanotoxicology
tion detected  using  the  reporter  dichlorodihydroﬂuorescein  was observed  in  whole  cells
and mitochondria  5  and  60 min  after  exposure  to AgNPs-1.  The  present  study  is  the  ﬁrst,
to  our  knowledge,  to  report the temporal  expression  and  intracellular  localisation  of ROS
induced  by  AgNPs.
© 2015  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. IntroductionThe development of nanomaterials as innovative cat-
alysts in cosmetics and pharmaceuticals has progressed
dramatically [1,2]. Although there are no reports of human
Abbreviations: AgNPs, silver nanoparticles; AgNO3, silver nitrate;
DCFH-DA, dichlorodihydroﬂuorescein diacetate; DLA, Dalton’s lym-
phoma ascites; ROS, reactive oxygen species; TEM, transmission electron
microscopy.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).health hazards, animal experiments show that amorphous
nanosilica causes complications in pregnancy, and carbon
nanotubes induce damage to the testis and cause mesothe-
lioma [3–5]. Moreover, silver nanoparticles (AgNPs) and
their coating agents are marketed as powerful antibacte-
rial agents with antineoplastic activity; however, there are
safety concerns [6–10].
AgNPs act as antineoplastic drugs by inducing apo-
ptosis. For example, Dalton’s lymphoma is a spontaneous
and highly invasive T-cell lymphoma that develops as an
ascitic tumour in mice and serves as a model for studying
tumorigenesis [6]. AgNPs induce apoptosis and reduce the
volume of Dalton’s lymphoma by activating caspase 3 [6].
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oreover, colloidal AgNPs induce apoptosis of the human
CF7 breast cancer cell line but do not affect the viability
f normal peripheral blood mononuclear cells [7].
After intravenous injection, 125I-labelled AgNPs accu-
ulate in the liver and spleen and to a lesser degree in the
ungs, bone and blood in vivo [8]. Moreover, AgNPs admin-
stered orally to rats for 28 days accumulate in the small
ntestine, stomach, liver, kidney and spleen, and small
mounts accumulate in brain and muscle tissues as well
9]. Such effective tissue accumulation of AgNPs warrants
urther investigation and drug design. However, the extent
f inﬂammation of the blood–brain barrier and induction of
he cytokines PGE2, TNF- and IL-1 in primary rat brain
icrovessel endothelial cells is inversely proportional to
he size of AgNPs [10]. Moreover, binding of AgNPs to
CNF/Fyu kinase in spermatogonial stem cells may  inhibit
ell proliferation [11]. Therefore, these toxicological issues
re important considerations for the effective use of AgNPs.
Induction of ROS by AgNPs is indisputably a primary
echanism of toxicity. Similarly, treatment with radiation
nd various chemicals directly and indirectly produce ROS,
eading to DNA damage and induction of inﬂammatory
ytokines [12]. Analysis of mouse ﬁbroblasts and human
epatocytes reveals that an increase in ROS levels induced
y AgNPs is accompanied by a reduction of mitochondrial
embrane potential, release of cytochrome C into the cyto-
ol, JNK activation and translocation of Bax to mitochondria
13,14]. The antiapoptotic protein Bcl2 is expressed at high
evels by human HCT116 colon cancer cells that are resis-
ant to AgNPs [13]. Further, AgNPs and Ag+ mediate ROS
eneration, including superoxide (O2•−), hydroxyl radicals
•OH) and hydrogen peroxide (H2O2) in cell-free systems
15,16]. Whether the toxicity of AgNPs toxicity is caused by
g+, the nanoparticle structure or other factors is unknown.
Therefore, it is important to determine the location
nd temporal expression of ROS induced by AgNPs. In
he present study, we used live-cell imaging with the ﬂu-
rescent ROS probe dichlorodihydroﬂuorescein diacetate
DCFH-DA) to investigate the spatiotemporal kinetics of
OS production induced by AgNPs and AgNO3.
. Materials and methods
.1. Cell culture
Cryopreserved BALB/3T3 A31-1-1 cells were obtained
rom the RIKEN Bioresource Centre (Ibaraki, Japan) and
ere thawed and used for experiments after varying
eriods. Cells were treated with trypsin and then sub-
ultured three times per week to maintain subconﬂuent
rowth. Cells were cultured in Eagle’s minimum essential
edium (Wako Chemicals) containing 5% foetal calf serum
t 37 ◦C in a humidiﬁed atmosphere containing 5% CO2.
.2. Silver nanoparticles and other reagents
We  purchased 70-nm AgNPs designated AgNPs-70
AGS-WP001) and 1-nm AgNPs designated AgNPs-1 (AGS-
P001C) from Polytech & Net, GmbH. Particle size
istributions were evaluated using dynamic light scatter-
ng (DLS) (Fig. 1), which was performed in Hank’s BalancedFig. 1. Physicochemical characterisation of silver nanoparticle suspen-
sions.
Salt Solution (HBSS) at 25 ◦C using an ELSZ-2 particle-size
analyser (Otsuka Electronics). AgNPs were suspended in
HBSS, sonicated for 5 min, and vortexed for 5 min  before
use. Silver nitrate (AgNO3) and DCFH-DA were purchased
from Sigma–Aldrich, Japan. Mito Tracker was purchased
from Invitrogen.
2.3. Cell cytotoxicity assay
The cytotoxicities of AgNPs and AgNO3 were deter-
mined using a colony formation assay. BALB/3T3 A31-1-1
cells were seeded at 100 cells per dish (60-mm diameter)
in culture medium. After incubation for 24 h, the cells were
treated for 60 min  with AgNPs-70, AgNPs-1 or AgNO3 at
1, 5 and 10 g/mL [17,18]. After 2 weeks, the cells were
ﬁxed with methanol, stained with Giemsa solution, and the
colonies were counted. Colonies comprising more than 50
cells were scored [19].
2.4. Live-cell ROS imaging
Intracellular ROS levels were assayed using DCFH-DA,
which is cleaved by nonspeciﬁc esterases to generate DCFH,
and quantitatively oxidised by ROS to generate ﬂuorescent
DCF. In the present study, the location of intracellular ROS
was imaged using the protocol as follows (Fig. 1): Cells
were seeded at 1 × 103 cells per multiwell glass bottom dish
(Matsunami). After incubation at 37 ◦C for 24 h, cells were
treated with 1 M Mito Tracker (Invitrogen) for 30 min,
washed twice with culture medium and then exposed to
AgNPs or AgNO3 for 5 or 30 min. After 2 or 27 min, the cells
were incubated with 10 M DCFH-DA for 3 min. Live-cell
imaging was  performed using a FluoView FV1000 confocal
laser scanning microscope (Olympus), and the images were
analysed using fv10-asw 2.0 viewer software (Olympus).
Cells were imaged using an inverted microscope (IX81,
Olympus) equipped with a 40× or 100× objective lens.
DCF or MitoTracker were excited at 473 nm or 559 nm,
respectively, and their emission was detected at 520 nm or
598 nm,  respectively. The assay was performed in triplicate
in three independent experiments.
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2.5. Transmission electron microscopy (TEM)
The intracellular distribution of AgNPs-1 was  deter-
mined using TEM. Cells were seeded at 1 × 103 cells per
microscope cover glass (Fisher scientiﬁc). After incubation
at 37 ◦C for 24 h, cells were treated with 5 g/mL AgNPs-1
for 5 or 60 min, ﬁxed in 0.1 M cacodylate buffer (pH 7.4)
containing 2.5% glutaraldehyde and 2.0% paraformalde-
hyde, ﬁxed again using 1% OsO4 in 0.1 M cacodylate buffer
(pH 7.4), stained en bloc with 0.5% aqueous uranyl acetate
and dehydrated using a graded series of ethanol concen-
trations. Samples were embedded in resin (Poly/Bed 812;
Polysciences, Inc.), and ultrathin sections were stained with
uranyl acetate and lead citrate and observed using an elec-
tron microscope (JEM-1010; JEOL).
3. Results and discussion
The purpose of the present study was to determine the
relationship of AgNP particle size to cytotoxicity and the
generation of ROS. For this purpose, we used AgNPs-70 and
AgNPs-1 as well as AgNO3 as a source of Ag+. The particle
sizes chosen are consistent with evidence that gave rise
Fig. 3. Location and temporal expression of intracellular ROS induced by AgNPs
30  min and stained with MitoTracker after 30 min. ROS imaging was  conducted 3Fig. 2. Cytotoxicity of AgNPs and AgNO3. The cell viability of BALB/3T3
cells was  determined using a colony formation assay described in Section
2. ND, Not detected. *P < 0.05 vs. control (ANOVA and Tukey’s HSD tests).
to the theory that smaller particles are more toxic. DLS
measurements using the ELSZ-2 particle-size analyser
show that the average particle diameter of AgNPs-70 was
63.5 nm,  the surface electric charge was  −0.98 mV and
the polydispersity index (PDI) was 0.238 (Table 1). The
. Cells were treated with 5 g/mL AgNO3, AgNPs-70 or AgNPs-1 for 5 or
 min  after the cells were labelled with DCFH-DA.
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Table  1
Physicochemical characterisation of silver nanoparticle suspensions.






















U70-nm AgNPs 63.5 ± 1.04 
1-nm AgNPs 1.2 ± 0.54 
ll data are expressed as the mean ± SD.
verage particle diameter of AgNPs-1 was 1.2 nm,  the
urface electric charge was −13.45 mV  and the PDI could
ot be measured (Table 1).
Next, we evaluated the cytotoxicity of AgNO3 and AgNPs
sing a colony formation assay. It is assumed that the
oxicity of silver nanoparticles is caused by silver ion or
anoparticle form and both [20]. Accordingly, the cell via-
ility was approximately 78% at 10-g/mL AgNO3, and,
pproximately 21% and 0% of cell viability were observed at
gNPs-70 and AgNPs-1, respectively, at the same Ag con-
entration. Thus, after 1-h treatments, toxicity of AgNPs
as predominantly mediated by nanoparticles form rather
han silver ion.
These results indicate that the smaller silver particles
ere more cytotoxic and are consistent with the tentative
heory that smaller AgNPs are more cytotoxic [20].
We next asked if this common theory applied to
he induction of ROS by AgNPs. For this purpose, we
reated cells with DCFH-DA for 3 min  before conducting
ntracellular imaging to avoid difﬁculties of the standard
0 min  treatment. We  determined that DCFH reacted
ith ROS and accumulated as DCF in the cytoplasm at
ig. 4. Fluorescence intensity proﬁle graphs of AgNP-induced mitochondrial RO
pper  and lower images and line charts show cells 60 min  after treatment with A0.238 ± 0.007 −10.98 ± 0.51
N.D. −13.45 ± 1.23
approximately 30 min, which would interfere with the
detection of ROS in organelles. DCF was detected in the
cytoplasm and mitochondria after exposure to AgNPs-1 for
5 min  (Fig. 3) but not to AgNPs-70 or AgNO3 (Fig. 3). After
60 min  exposure to AgNPs-70 and AgNPs-1, but not to
AgNO3, increased the levels of DCF were mainly observed
in mitochondria (Figs. 3 and 4).
When cells were exposed to amorphous nanosilica
particles, which produce ROS through plasma mem-
brane NADPH oxidase under the experimental conditions
employed here (see Section 2.4), DCF was  observed
throughout the entire cell, and the ﬂuorescence intensity
increased with time (Supplementary Fig. 1) [21]. More-
over, the ﬂuorescence intensity proﬁles of MitoTracker
and DCF were almost completely consistent. In particular,
DCF ﬂuorescence was  detected between the peaks of the
mitochondrial membrane, which were swollen by AgNPs-
1 (Fig. 4). These results strongly suggest that AgNPs-70
and AgNPs-1 induced mitochondrial ROS production in a
size-dependent manner (Fig. 3). Moreover, the increasing
tendency of the ﬂuorescence intensity was  apparent in the
presence of AgNPs-1 than in the presence of AgNPs-70,
S. The graphs show the intensity of DCF and MitoTracker ﬂuorescence.
gNPs-1 and AgNPs-70, respectively.
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dria (whFig. 5. TEM images of ultrathin cell sections. The image shows mitochon
for  5 min  (B) and 60 min (C).
indicating increased mitochondrial ROS production in the
presence of smaller AgNPs (Figs. 3 and 4). It was thought
that AgNO3 could be used as a model for Ag ion because
it had less cytotoxicity due to weak ROS production by
mitochondria (Figs. 2 and 3).
To determine whether AgNPs directly induced mito-
chondrial ROS, we used TEM to examine the localisation
of AgNPs-1 in mitochondria. AgNPs-1 were not detected
in mitochondria after 5 and 60 min  of exposure (Fig. 5);
however, it was difﬁcult to visualise 1-nm particles.
However, because AgNPs-1 induced ROS production by
mitochondria, this may  be an indirect effect associated
with redox signalling by intracellular ROS. The contribu-
tion of intracellular ROS to redox signalling in intracellular
organelles indicates roles in addition to the oxidation
of DNA and lipids. Increased mitochondrial ROS levels
affect redox potentials and the thiol-disulphide redox
states of ATP/ADP translocators, causing the opening of
permeability transition pores and the induction of apo-
ptosis [22]. Moreover, increased levels of intranuclear
ROS enhance hypoxia-sensitive gene expression by oxi-
dising DNA encoding hypoxia response elements [23].
Speciﬁcally, the plasma membrane NADPH oxidase fam-
ily member Nox3, which is induced by ROS, promotes
TNF production and Fas-mediated apoptosis through c-
Jun N-terminal kinase signalling [24,25]. ROS induce the
expression of Nox4, which resides in the endoplasmic
reticulum, and mediates the oxidation of PTP1B and EGF
signalling [26]. Therefore, the production of ROS by spe-
ciﬁc organelles triggers apoptosis in a manner similar to
that induced by the cytotoxic effects of AgNPs.
4. Conclusions
The present report provides the evidence acquired using
live-cell imaging that AgNPs induced the production of
ROS by mitochondria after only 5 and 60 min. Further, the
smaller AgNPs particles induced higher levels of mitochon-
drial ROS. Increased mitochondrial ROS induce cell death
by promoting intrinsic apoptotic pathways [27,28], and
we conclude that AgNPs induce apoptosis by this mech-
anism. It is possible that increased oxidation of DNA is
caused by cellular internalisation of AgNPs. However, the
mechanisms of nanoparticle internalisation are unclearite arrow) in untreated cells (A) and cells treated with 5 g/mL AgNPs-1
and may  be associated with destabilisation of cell mem-
branes [29,30]. AgNPs are powerful inducers of cell death
compared with other nanoparticles. We  hypothesise that
AgNPs induce cytotoxicity after they are internalised.
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